SPDR S&P Biotech ETF Rating $82.95 +1.07 (+1.31%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.76Holdings in XBI have an aggregate rating of Moderate Buy based on 772 analyst ratings issued in the past year covering 50 companies (77.8% of the portfolio).XBI Aggregate Price Target$82.95High Prediction$82.95Average Prediction$82.95Low Prediction$82.95Holdings in XBI have an aggregate price target of $82.95 and a range of $82.95 to $82.95 covering 50 companies (77.8% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.82%NTRANatera$150.93-2.6%2.8963 of 5 stars3.00$175.76 16.5%16Positive News2.71%VRTXVertex Pharmaceuticals$509.50+1.2%3.939 of 5 stars2.64$514.91 1.1%25Upcoming EarningsAnalyst RevisionPositive News2.70%INSMInsmed$72.00+0.8%4.344 of 5 stars3.00$94.00 30.6%16News CoveragePositive News2.66%ALNYAlnylam Pharmaceuticals$263.24+2.4%4.307 of 5 stars2.77$315.58 19.9%26Upcoming EarningsAnalyst DowngradeNews CoveragePositive News2.55%UTHRUnited Therapeutics$303.09+0.8%4.9052 of 5 stars2.67$390.17 28.7%12Earnings ReportAnalyst RevisionNews CoveragePositive NewsGap Up2.55%NBIXNeurocrine Biosciences$107.69+0.4%4.862 of 5 stars2.86$160.90 49.4%22Analyst ForecastAnalyst Revision2.52%GILDGilead Sciences$106.54+2.2%4.7028 of 5 stars2.78$109.43 2.7%27Earnings ReportDividend AnnouncementAnalyst Revision2.47%EXASExact Sciences$45.64+1.9%4.3984 of 5 stars2.95$69.25 51.7%22Upcoming Earnings2.44%AMGNAmgen$290.92+0.8%4.0678 of 5 stars2.43$310.57 6.8%23Upcoming EarningsPositive News2.36%INCYIncyte$62.66+3.7%4.7148 of 5 stars2.21$73.94 18.0%19Earnings ReportAnalyst ForecastNews Coverage2.33%BIIBBiogen$121.08+0.8%4.6901 of 5 stars2.38$201.93 66.8%32Upcoming EarningsAnalyst DowngradeAnalyst Revision2.29%MDGLMadrigal Pharmaceuticals$333.91-2.0%3.7477 of 5 stars3.00$409.00 22.5%9Upcoming EarningsNews CoveragePositive NewsGap Down2.24%ABBVAbbVie$195.15+0.8%4.6152 of 5 stars2.89$211.41 8.3%27Earnings ReportAnalyst ForecastAnalyst Revision2.24%REGNRegeneron Pharmaceuticals$598.76+5.2%4.8295 of 5 stars2.88$912.20 52.3%26Earnings ReportDividend AnnouncementAnalyst ForecastHigh Trading Volume2.14%BPMCBlueprint Medicines$89.50+1.2%2.5612 of 5 stars2.68$124.53 39.1%22Upcoming EarningsAnalyst ForecastNews CoveragePositive News2.12%EXELExelixis$39.15+1.6%4.0767 of 5 stars2.50$37.59 -4.0%20Short Interest ↑Analyst RevisionPositive News1.97%BMRNBioMarin Pharmaceutical$63.69+0.6%4.9207 of 5 stars2.70$93.14 46.2%23Upcoming EarningsPositive News1.94%MRNAModerna$28.54+2.6%4.3377 of 5 stars2.04$58.70 105.7%24Upcoming Earnings1.77%TGTXTG Therapeutics$45.51+3.8%3.3352 of 5 stars2.83$40.67 -10.6%6Upcoming EarningsNews CoveragePositive NewsGap Down1.74%BBIOBridgeBio Pharma$38.36+5.3%4.5442 of 5 stars2.92$57.09 48.8%12Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap DownHigh Trading Volume1.66%HALOHalozyme Therapeutics$61.42+1.0%4.0044 of 5 stars2.60$62.89 2.4%10Upcoming EarningsInsider TradeAnalyst Revision1.53%RVMDRevolution Medicines$40.38-0.7%3.7672 of 5 stars3.00$66.67 65.1%12Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.48%CYTKCytokinetics$42.84+3.8%4.2589 of 5 stars2.94$79.13 84.7%18Upcoming EarningsInsider Trade1.44%SMMTSummit Therapeutics$24.12+2.1%2.6628 of 5 stars3.00$37.50 55.5%10Upcoming EarningsAnalyst ForecastGap Down1.40%CRSPCRISPR Therapeutics$38.67+3.4%2.7944 of 5 stars2.48$73.11 89.0%21Upcoming Earnings1.33%SRPTSarepta Therapeutics$62.40+2.5%4.7339 of 5 stars2.83$158.70 154.3%241.28%ROIVRoivant Sciences$11.62+2.9%2.1639 of 5 stars3.00$17.50 50.6%4Positive News1.27%IONSIonis Pharmaceuticals$30.71+3.0%4.1993 of 5 stars2.70$56.44 83.8%20Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap Up1.21%ADMAADMA Biologics$23.80-1.3%1.481 of 5 stars3.25$22.50 -5.5%4News CoveragePositive NewsGap Down1.12%VKTXViking Therapeutics$28.87+3.3%4.4756 of 5 stars3.00$87.15 201.9%14Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage1.07%SWTXSpringWorks Therapeutics$46.30+0.1%1.9516 of 5 stars2.13$52.57 13.5%8Upcoming EarningsAnalyst ForecastNews CoverageHigh Trading Volume1.04%KRYSKrystal Biotech$169.88-0.4%4.9031 of 5 stars3.00$222.71 31.1%8Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.03%ALKSAlkermes$28.774.6092 of 5 stars2.58$38.08 32.4%12Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.03%PCVXVaxcyte$35.84+3.1%3.0068 of 5 stars3.10$136.50 280.9%10Upcoming EarningsPositive News0.98%RNAAvidity Biosciences$32.65+1.5%2.8344 of 5 stars3.00$66.69 104.3%13Positive NewsGap Down0.93%TWSTTwist Bioscience$38.32-3.4%3.5988 of 5 stars2.70$52.80 37.8%10Upcoming EarningsPositive NewsGap Down0.93%NUVLNuvalent$76.75+1.2%1.8954 of 5 stars2.90$115.50 50.5%10News CoveragePositive News0.92%ACLXArcellx$64.95+0.4%1.8405 of 5 stars3.14$110.67 70.4%14News CoveragePositive News0.91%RYTMRhythm Pharmaceuticals$65.190.0%3.7075 of 5 stars3.00$74.92 14.9%13Upcoming EarningsNews CoveragePositive News0.88%VCYTVeracyte$30.50-2.8%3.9653 of 5 stars2.70$42.60 39.7%10Upcoming EarningsShort Interest ↑Gap Down0.87%SRRKScholar Rock$32.91+0.4%4.0517 of 5 stars3.00$42.67 29.6%6Upcoming EarningsInsider TradeNews CoveragePositive News0.84%RXRXRecursion Pharmaceuticals$5.59-2.3%2.2177 of 5 stars2.33$8.20 46.7%6Gap Down0.83%APLSApellis Pharmaceuticals$19.21+5.5%4.1083 of 5 stars2.65$45.28 135.7%20Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage0.82%SLNOSoleno Therapeutics$74.86-0.5%4.6455 of 5 stars3.20$104.67 39.8%10Upcoming EarningsPositive News0.81%RAREUltragenyx Pharmaceutical$38.98+2.4%4.3462 of 5 stars2.93$92.79 138.0%14Upcoming EarningsShort Interest ↑News CoveragePositive News0.79%CRNXCrinetics Pharmaceuticals$33.39+0.2%3.6599 of 5 stars2.92$73.00 118.6%13News CoveragePositive News0.75%ACADACADIA Pharmaceuticals$14.60+1.2%4.2577 of 5 stars2.50$23.87 63.5%16Upcoming EarningsAnalyst Forecast0.71%AKROAkero Therapeutics$45.61+6.0%3.7887 of 5 stars3.00$76.29 67.3%9Insider TradeNews CoveragePositive News0.69%PTCTPTC Therapeutics$49.84+0.6%4.0644 of 5 stars2.53$63.92 28.3%15Upcoming EarningsNews CoveragePositive News0.66%AGIOAgios Pharmaceuticals$29.69+2.0%4.309 of 5 stars2.56$56.57 90.5%9Upcoming EarningsNews CoveragePositive News This page (NYSEARCA:XBI) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBI Stock Free XBI Stock Alerts